Source
From SEC EDGAR
171 releases originally issued via SEC EDGAR. The issuing organizations are responsible for their content.
Viridian Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Business Progress
- $24.7 million in Lumvoa™ (veligrotug-vvze) net product revenue with more than 100 patients on therapy at the end of Q3 2026 -
Trinity Capital Reports Third Quarter 2026 Financial Results
Return on Average Equity climbs to 15.5% in Q3
MoonLake Reports Third Quarter 2026 Financial Results and Provides a Business Update
•Biologics License Application for sonelokimab submitted to the U.S. Food and Drug Administration for the treatment of adults and adolescents with…
MARRIOTT VACATIONS WORLDWIDE Corp
Marriott Vacations Worldwide Reports
Ex. 99.1
XPEL Reports Revenue of $137.8 million; Revenue Growth of 9.9% in Third Quarter 2026
The New York Times Company Reports Third-Quarter 2026 Results
SCOTTS MIRACLE-GRO CO
ScottsMiracle-Gro Reports Strong Fiscal 2026 Full-Year Results
SharkNinja Reports Third Quarter 2026 Results
Raises Fiscal Year 2026 Outlook Across Key Metrics on Strong Operational Performance
FTC Solar Announces Third Quarter 2026 Financial Results
Third Quarter Highlights and Recent Developments
Solstice Advanced Materials Inc.
Solstice Advanced Materials Reports Third Quarter 2026 Results
News release
TREX COMPANY REPORTS Strong Third QUARTER 2026 RESULTS, DELIVERING BACK-TO-BACK RECORD QUARTERS